Home › NDC Lookup › RxCUI directory › RxCUI 2667336

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio] — RxCUI 2667336

RxNorm drug concept · Semantic branded drug
RxCUI 2667336 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2667336
Official name0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.68 ML Entyvio 159 MG/ML Prefilled Syringe; ENTYVIO 108 MG in 0.68 ML Prefilled Syringe; Entyvio 108 MG per 0.68 ML Prefilled Syringe
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)34,599 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vedolizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Neither, actually. Entyvio is a biologic medication — a specially engineered antibody that targets a very specific protein on certain immune cells. Instead of suppressing your whol...
  • What exactly does Entyvio do — is it like a steroid or a chemotherapy drug?
  • Both options are possible. You'll need to start with a few IV infusions at a clinic or infusion center — those first doses at Week 0, Week 2, and Week 6 have to be done by a health...
  • Do I have to go to a clinic every time, or can I do the injections at home?
📖 Read our full Vedolizumab Injection guide →

🕸️ Concept Web — How 0.68 ML vedolizumab 159 MG/ML Prefilled Syringe... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio] RxCUI 2667336

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vedolizumab 1538097
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Entyvio 1538138
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vedolizumab Prefilled Syringe 2667331
    • Vedolizumab Injectable Product 1538135
    • Vedolizumab Prefilled Syringe [Entyvio] 2667335
    • Entyvio Injectable Product 1538141
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Vedolizumab 159 MG/ML [Entyvio] SBDC · 2667334
  • Vedolizumab Prefilled Syringe [Entyvio] SBDF · 2667335
  • Entyvio Injectable Product SBDG · 1538141
  • Entyvio BN · 1538138

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2667336 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64764-0107-11 1 TRAY in 1 CARTON (64764-107-11) / 1 SYRINGE in 1 TRAY (64... ENTYVIO Takeda Pharmaceuticals America, Inc. 2023-09-27
64764-0108-21 1 TRAY in 1 CARTON (64764-108-21) / 1 SYRINGE in 1 TRAY (64... ENTYVIO Pen Takeda Pharmaceuticals America, Inc. 2023-09-27
64764-0300-20 1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1... Entyvio Takeda Pharmaceuticals America, Inc. 2014-05-20
Observed labelers: Takeda Pharmaceuticals America, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J3380 Inj vedolizumab iv 1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.